SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Stuart Scolnik who wrote (3501)12/12/1997 10:48:00 AM
From: Musa Goksel Bulat  Respond to of 23519
 
TO ALL

VVUS traded for this low in August 95 with -$.87 earnings for previous 12 months. At that time there were big uncertanities. Now it is trading around $12 after selling over $100 million and earning $.86 in last 9 months in 1997.

CC was positive and shorts are still attacking the stock.
DOES ANYONE HAVE ANY IDEA ABOUT WHAT BAD NEWS ELSE COULD THERE BE OTHER THAN VIAGRAS BEING 100% EFFECTIVE TO JUSTIFY THIS PRICE ACTION.

Go look at AMZN they haven't made a penny yet. Big competition is coming from BKS and borders. (booksellers). AMZN is selling at 13 times sales with $1.3billion market cap and they don't expect to make any money during 1998.

How someone can justify shorting VVUS at this price?



To: Stuart Scolnik who wrote (3501)12/12/1997 10:49:00 AM
From: Zebra 365  Read Replies (1) | Respond to of 23519
 
Regrdless of the effect of the conference call, people who have received a federal margin call must sell before the weekend, or their broker must sell them out involuntarily. A sad fact of margin requirements.

If we see a positive response to the CC, it will probably come from short covering if the stock appears to base today.

Zebra


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News